Articles By Jack Cush, MD
Anti-inflammatory Diet Control of Rheumatoid Arthritis
By Jack Cush, MD
09 April 2021
The TOMORROW study assessed the relationship between diet and disease activity in rheumatoid arthritis (RA) patients and has shown that RA patients are more likely to have higher inflammatory diets, but that a change to an anti-inflammatory diet resulted in lower disease activity scores.
Read Article
RheumNow Podcast – Mistakes with Steroids
By Jack Cush, MD
08 April 2021
Dr Jack Cush gives his spin on this week's RheumNews and Rheum Research from RheumNow.com.
Read Article
Overview of New VEXAS Syndrome
By Jack Cush, MD
08 April 2021
Medscape offers up an informative overview of the newly described syndrome called VEXAS discovered by researchers at the National Institutes of Health.
Read Article
GLP-1 Therapy in Knee Osteoarthritis
By Jack Cush, MD
08 April 2021
Knee osteoarthritis is best managed by weight loss, as the effects of most analgesic therapies have been marginal and debatable. The use of anti-diabetic glucagon-like peptide-1 therapies have demonstrated significant weight loss benefits; hence this trial evaluated the potential weight loss and pain relieving effects of liraglutide in obese patients with KOA.
Read Article
Implementing Smoking Cessation Programs
By Jack Cush, MD
07 April 2021
Rheumatologists are keen to the effects of smoking (increased arthritis risk, worse outcomes, blunted DMARD responses, added cardiopulmonary risks), but often do not have the resources or plan to encourage or implement smoking cessation from the rheumatology clinic. A new study details the success of a rheumatology staff‐driven protocol, Quit Connect, to increase the rate of electronic referrals to free, state‐run tobacco quit lines.
Read Article
Rheumatology Care Derailed by COVID-19
By Jack Cush, MD
06 April 2021
A survey study from the ArthritisPower PPRN or CreakyJoints database shows that during the COVID-19 pandemic patient care was substantially affected in unforeseen ways.
Read Article
Reactogenicity Following mRNA COVID-19 Vaccines
By Jack Cush, MD
06 April 2021
JAMA has published the real-world reporting of mRNA vaccine side effects (reactogenicity) gathered from CDC V-safe Surveillance system and shows that local and systemic reactions were often mild and transient and most commonly seen during the first day following their second dose.
Read Article
Cost Efficacy of Knee Replacement in Obese Osteoarthritis
By Jack Cush, MD
05 April 2021
Total knee replacement (TKR) in obese patients with end-stage knee osteoarthritis appears to be a beneficial and cost-effective strategy for treating. The only potential limitation is a greater risk for adverse events in those with a body mass index (BMI) of 40 kg/m2 or greater.
Read Article
Rituximab in Systemic Sclerosis?
By Jack Cush, MD
05 April 2021
No drug is FDA approved to manage the skin or joint complaints of systemic sclerosis (SSc); a recent metanalysis suggests that rituximab may improve skin score and disease activity indices (DAS, mRSS) while stabilizing organ involvement in SSc patients.
Read Article
RheumNow Podcast – Upadacitinib Wins in PsA (4.2.2021)
By Jack Cush, MD
02 April 2021
Dr Jack Cush reviews the news and Journal reports and takes "Back Talk" questions from viewers.
Read Article